On 11/15/24, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock suffered a major decline of -12.6%, closing at $9.17. Moreover, this decline was accompanied by above average trading volume at 126% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -20.9% during the last week.
Current PriceTarget Research Rating
EyePoint Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. EyePoint Pharmaceuticals has a neutral Appreciation Score of 49 but a very low Power Rating of 1, triggering the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment